Hemorrhagic Proctocolitis Overview

Save information for later
Sign Up

Learn About Hemorrhagic Proctocolitis

What is the definition of Hemorrhagic Proctocolitis?
Hemorrhagic proctocolitis is a condition in which there is inflammation in the lining of the colon and rectum that causes bleeding. Hemorrhagic proctocolitis has many possible causes.
What are the symptoms of Hemorrhagic Proctocolitis?
Symptoms of hemorrhagic proctocolitis may include abdominal cramps, diarrhea, rectal and colon inflammation, gastrointestinal bleeding, increased bowel movements, a feeling of fullness in rectum, rectal bleeding, rectal pain, pain of the left side of abdomen, pain with bowel movements, blood in the stool, blackened stool, mucus in stool, and anemia.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hemorrhagic Proctocolitis?
Treatment for hemorrhagic proctocolitis depends on the cause and may include antibiotics, antiviral agents, anti-inflammatory medications, medications to ease bowel movements, and probiotics.
Who are the top Hemorrhagic Proctocolitis Local Doctors?
Stephen B. Hanauer
Elite in Hemorrhagic Proctocolitis
Dr. Stephen B. Hanauer
Gastroenterology
Elite in Hemorrhagic Proctocolitis
Dr. Stephen B. Hanauer
Gastroenterology

Northwestern Medical Faculty Foundation

250 E Superior St, 
Chicago, IL 
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Hanauer is a Gastroenterologist in Chicago, Illinois. Dr. Hanauer and is rated as an Elite provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Colonoscopy, and Ileostomy. Dr. Hanauer is currently accepting new patients.

David P. Hudesman
Elite in Hemorrhagic Proctocolitis
Dr. David P. Hudesman
Gastroenterology
Elite in Hemorrhagic Proctocolitis
Dr. David P. Hudesman
Gastroenterology

New York University

240 E 38th St, 
New York, NY 
212-263-7300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Hudesman is a Gastroenterologist in New York, New York. Dr. Hudesman and is rated as an Elite provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Hemorrhagic Proctocolitis, Ulcerative Colitis, Viral Gastroenteritis, Small Bowel Resection, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Bo C. Shen
Elite in Hemorrhagic Proctocolitis
Dr. Bo C. Shen
Gastroenterology
Elite in Hemorrhagic Proctocolitis
Dr. Bo C. Shen
Gastroenterology

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
Experience:
43+ years
Languages Spoken:
English
Offers Telehealth

Bo Shen is a Gastroenterologist in New York, New York. Dr. Shen has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Endoscopy.

View All Doctors
What are the latest Hemorrhagic Proctocolitis Clinical Trials?
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
Enrollment Status: Recruiting
Publish Date: April 17, 2025
Intervention Type: Other
Study Phase: Not Applicable

Summary: The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and UC are ver...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A PHASE 1B, TWO-PART, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ORAL PF-07054894 IN ADULT PARTICIPANTS AGED 18-75 YEARS WITH MILD TO SEVERE ULCERATIVE COLITIS
A PHASE 1B, TWO-PART, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ORAL PF-07054894 IN ADULT PARTICIPANTS AGED 18-75 YEARS WITH MILD TO SEVERE ULCERATIVE COLITIS
Enrollment Status: Recruiting
Publish Date: April 16, 2025
Intervention Type: Drug
Study Phase: Phase 1

Summary: This is a study to learn if the experimental medicine (called PF-07054894) is safe, effective, and how it is processed in adult people with ulcers in the colon.

View All Clinical Trials